Persistent Systems Limited Achieves Databricks Healthcare AI Specialization; Shares Slip 0.67%
By HDFC SKY | Updated at: May 7, 2026 04:39 PM IST
Persistent Systems Limited achieved the Databricks Brickbuilder Specialization for Healthcare and Life Sciences, strengthening its AI and regulated data platform capabilities, while shares slipped 0.67% on May 7.

Mumbai, May 7: Persistent Systems Limited said it has achieved the Databricks Brickbuilder Specialization for Healthcare and Life Sciences (HLS).
The recognition highlights Persistent’s growing focus on enterprise AI, governed data platforms and regulated industry solutions, particularly in healthcare and life sciences where adoption of AI-driven analytics is accelerating rapidly, according to a company press release submitted to the Bombay Stock Exchange and the National Stock Exchange of India.
Persistent Earns Databricks Healthcare And Life Sciences Recognition
The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
According to the company, the Databricks Brickbuilder Specialization validates Persistent’s ability to deliver production-grade governed data and artificial intelligence solutions on the Databricks Data Intelligence Platform for highly regulated healthcare and life sciences environments.
Persistent said the specialization supports healthcare and life sciences organisations in consolidating multimodal datasets including clinical records, genomics, imaging and patient data into AI-ready enterprise platforms.
The company stated that these solutions are aimed at accelerating clinical development, improving patient outcomes and enabling AI deployment across regulated healthcare workflows.
The release also highlighted the use of Databricks technologies such as Delta Lake, Unity Catalog and Mosaic AI to support governance, compliance and enterprise-scale AI implementation.
Persistent added that its collaboration with Databricks has expanded through co-creation initiatives and go-to-market programs focused on healthcare and life sciences enterprises.
According to the company, its AI and data solutions have already been used in areas including clinical trial optimisation, biomarker discovery, pharmacovigilance and AI-driven operational efficiency programs.
The recognition comes as healthcare organisations globally continue increasing investments in AI-powered diagnostics, data infrastructure and advanced analytics to improve operational efficiency and patient care outcomes.
Stock Market Snapshot
Persistent Systems share price traded lower despite the technology recognition announcement.
The stock was quoted at ₹4,980.30 on the NSE at 2:59 p.m. IST on May 7, down 0.67% from the previous close, according to exchange data.
During the trading session, the stock moved within a range of ₹4,911.50 to ₹5,074.40.

Persistant Systems Share Price as of May 07, Source: NSE
Persistent Expands AI And Enterprise Data Capabilities
Persistent Systems Limited operates in the digital engineering, cloud transformation and AI-led technology services segment.
The company provides software engineering, enterprise modernisation, data analytics, customer experience transformation and intelligent automation services across multiple industries.
Persistent said it currently operates in more than 27 countries with a workforce of over 18,000 employees globally.
The company has increasingly focused on building AI-ready enterprise platforms and industry-specific solutions across healthcare, life sciences and financial services sectors.
Conclusion
The Databricks Brickbuilder Specialization strengthens Persistent Systems’ credentials in healthcare-focused AI and regulated data platform services.
Source:
- https://www.nseindia.com/get-quote/equity/PERSISTENT/Persistent-Systems-Limited
- https://nsearchives.nseindia.com/corporate/PERSISTENTUSER1_07052026123410_PSLPressReleaseMay72026signed.pdf
Disclaimer
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please Note: The information shared is intended solely for informational purposes and does not make any investment recommendations

